NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $17,676,000 | -15.8% | 242,668 | -8.7% | 0.11% | -18.7% |
Q3 2016 | $20,984,000 | -12.4% | 265,752 | -8.5% | 0.14% | -13.1% |
Q2 2016 | $23,967,000 | -30.4% | 290,470 | -38.9% | 0.16% | -34.7% |
Q1 2016 | $34,427,000 | -18.5% | 475,241 | -3.2% | 0.24% | -20.7% |
Q4 2015 | $42,254,000 | -19.6% | 491,099 | -14.1% | 0.31% | -21.8% |
Q3 2015 | $52,574,000 | -8.3% | 571,952 | -1.9% | 0.40% | +1.3% |
Q2 2015 | $57,316,000 | +121.5% | 582,831 | +122.1% | 0.39% | +121.6% |
Q1 2015 | $25,873,000 | +5.7% | 262,383 | -0.6% | 0.18% | +4.8% |
Q4 2014 | $24,470,000 | -6.3% | 264,083 | -4.8% | 0.17% | -10.6% |
Q3 2014 | $26,118,000 | +2.0% | 277,464 | -1.9% | 0.19% | +7.4% |
Q2 2014 | $25,600,000 | +5.7% | 282,789 | -0.7% | 0.18% | +4.8% |
Q1 2014 | $24,221,000 | -20.9% | 284,882 | -25.2% | 0.17% | -16.9% |
Q4 2013 | $30,625,000 | +1.1% | 381,005 | -3.5% | 0.20% | -6.5% |
Q3 2013 | $30,290,000 | +8.0% | 394,864 | -0.5% | 0.22% | +0.9% |
Q2 2013 | $28,055,000 | – | 396,756 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |